Prestige BioPharma
Focus: Prestige BioPharma is an oncology-focused biologics and biosimilars company headquartered in Singapore with a clinical-stage pipeline. The company operates as a regional player in Asia-Pacific with emerging clinical programs.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Prestige BioPharma
AI assessmentNot HiringNo open roles listed right now. Follow Prestige BioPharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
HD201
Healthy VolunteersClinical Trials (1)
NCT03776240A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects
Phase 1Help build intelligence for Prestige BioPharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.